Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.
Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.
复制标题
使用 ELISpot 测定研究接种疫苗和 HBV 感染人群中 HBs 特异性 B 细胞反应
DOI:
10.1038/s41426-018-0034-0
复制
发表时间:
2018-02-16
影响因子:
13.2
通讯作者:
Wu C
中科院分区:
文献类型:
--
作者:
Tian C;Chen Y;Liu Y;Wang S;Li Y;Wang G;Xia J;Zhao XA;Huang R;Lu S;Wu C
Hepatitis B surface antibody (HBsAb) plays a critical role in protecting against infection of hepatitis B virus (HBV) and were extensively studied in literature. At the same time, the status of hepatitis B surface antigen (HBs)-specific B cells in both vaccinated and HBV infected people received limited attention. In the current study, we adopted a highly specific B-cell Enzyme Linked ImmunoSpot (ELISpot) assay to analyze HBs-specific B cells in various clinical settings: healthy individuals with the history of HBV vaccination before and after receiving an extra HBV vaccine boost, people chronically infected with HBV (CHB) in various clinical stages, with or without a particular type anti-viral treatment, or whether receiving a dose of HBV vaccine. In all of these cases, B-cell ELISpot assay was used effectively in enumerating the frequency of HBs-specific B cells. While the focus of the current report was to establish the utility of this assay for HBV research, a number of interesting observations were made in this pilot study based on the profiles and dynamics of HBs-specific B cells in various conditions. Such information is useful to guide the future work in designing novel therapeutic strategies against CHB.
登录
查看更多内容
影响因子:
7.3
作者:
Fink K
通讯作者:
Fink K
影响因子:
2.2
作者:
CZERKINSKY, CC;NILSSON, LA;TARKOWSKI, A
通讯作者:
TARKOWSKI, A
影响因子:
4.3
作者:
Tang, Ceen-Ming;Yau, Tung On;Yu, Jun
通讯作者:
Yu, Jun
影响因子:
11.8
作者:
Lucia, Marc;Crespo, Elena;Bestard, Oriol
通讯作者:
Bestard, Oriol
影响因子:
168.9
作者:
Trepo, Christian;Chan, Henry L. Y.;Lok, Anna
通讯作者:
Lok, Anna